calciphylaxis/albumin

Background The majority of patients reaching end-stage renal disease (ESRD) and dialysis have vascular calcifications. Those vascular calcifications tend to increase mortality in this specific population. It has been shown that high scores of vascular calcifications in a healthy patient with no

Comparative study including - 20 consecutive patients with Martorell HYTILU - 10 consecutive patients with Calciphylaxis (calcific uremic arteriolopathy) - 20 patients with venous ulcer The following parameters are measured in the blood serum: White blood count; c-reactive protein; creatinine;

Calciphylaxis or calcific uremic arteriolopathy is an infrequently occurring although debilitating vasculopathy seen primarily in patients with end stage renal disease (ESRD) which almost always affects the skin. It has a prevalence rate ~4 % in long term hemodialysis patients, with 1-year survival